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Abstract
Introduction: Dysphagia and weight loss are alarming symptoms that warrant urgent assessment.
Case presentation: We present a case report of dysphagia secondary to oesophageal dysmotility
attributed to a paraneoplastic manifestation of an occult renal cell carcinoma.
Conclusion: We believe this patient’s dysphagia was a paraneoplastic manifestation of the renal cell
tumour, an association that has never been previously reported. This case demonstrates the need to
look for alternative causes for dysphagia if initial investigation and treatment are unhelpful.
Importantly, this must include the consideration of a paraneoplastic process secondary to an occult
neoplasm.
Introduction
Dysphagia and weight loss are alarming symptoms that
warrant urgent assessment to determine its cause and
initiate appropriate treatment.
Here we report a case of dysphagia secondary to
oesophageal dysmotility which was attributed to a
paraneoplastic manifestation of an occult renal cell
carcinoma.
Case presentation
A previously well 55 year old Caucasian male presented to
gastroenterology out patients clinic in November 2003,
with a three week history of worsening dysphagia to solids
and weight lossof 4 kilograms. Hedescribed a sensation of
food sticking at the level of the lower sternum. He had
suffered in the past with mild heartburn for which he took
a proton pump inhibitor on an as required basis. He was a
married and worked as an accountant. He had never
smoked. Physical examination including the body mass
index and blood pressure was unremarkable.
Initial investigations revealed proteinuria (++) on urine
dipstick, a haemoglobin of 11.8 (normal indices) with an
otherwise normal blood count and film. Urea and
electrolytes, estimated glomerular filtration rate, liver
enzymes, thyroid stimulating hormone, random blood
glucose, bone profile, haematinics and urine culture &
sensitivity were normal. The ESR was 96 mm/hour.
Unfortunately 24 hour urinary protein quantification
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did not suggest nephrotic or nephritic syndrome.
Oesophagogastroduodenoscopy including biopsies from
the mid and lower third of oesophagus were normal thus
excluding eosinophilic oesophagitis.
Although a liquid barium swallow showed no abnorm-
ality, a swallow with a solid medium (bread soaked in
barium) detected a significantly abnormal non-specific
dysmotility of the lower oesophagus (Figure 1a,b). This
was performed because the use a solid medium during a
barium swallow increases the sensitivity of the test by
generating a greater amplitude and duration of peristalsis
[1]. The dysmotility that was seen was confirmed with
oesophageal manometry.
A chest radiograph obtained during his barium swallow
identified a “coin shaped” lesion in the periphery of the
left lower lobe of the lung (Figure 2). On the same day his
ultrasound scan of the abdomen detected a mass arising
from the left kidney measuring 8x6x6 cms. A computed
tomography scan confirmed a large tumour arising from
the left kidney with renal vein involvement, and a left sub-
pleural lesion of uncertain nature, but suspicious of a
metastasis (Figure 3).
Immunological tests were negative for autoantibodies,
extractable nuclear antigens, anti-centromere, anti-topoi-
somerase-I (Scl-70) as well as the anti-neuronal antibodies
(anti-Hu, anti-Yo and anti-Ri).
The patient was given regular metoclopramide and dietary
input to optimise his nutritional status. He underwent a
left radical nephrectomy for a poorly differentiated renal
cell carcinoma (stage T3b, N0, Mx) at the end of December
2003. He was discharged home after an uneventful post-
operative course.
He was reviewed by the cardiothoracic surgeons and
respiratory physicians with regards to the lung lesion.
Serial CT scans showed that the lesion slowly decreased in
Figure 1. (A) Barium Swallow Radiograph - Liquid medium flowing freely. (B) Barium Swallow Radiograph - Solid medium
(bread soaked in barium) is been held up in lower oesophagus.
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period. A PET scan was normal 6 months post-operatively.
The lesion was therefore deemed to be benign. Surveil-
lance CT scans are been carried out every 12 months, as
pulmonary metastases from renal cell carcinomas can
regress spontaneously following removal of the primary
lesion, yet the long-term consequence is unknown [2].
The dysphagia that prompted the initial assessment had
resolved completely by the time of review in the
gastroenterology clinic a few weeks after surgery. Repeat
oesophageal manometry and pH study at 12 months after
presentation was normal. His renal functions have
remained stable. He remains well and annual CT scan
surveillance has remained normal to date.
Discussion
Many types of malignancies are associated with psuedoa-
chalasia leading to dysphagia. They may result in intra-
luminal narrowing, extra luminal compression, metabolic
disturbance and paraneoplastic effects such as endocrine
abnormalities eg: hypercalcaemia. There may also be a
paraneoplastic interference with the myenteric neural
plexus that controls and co-ordinates the swallowing
mechanism. The myenteric plexus may be infiltrated
directly, or attacked by autoantibodies generated by the
host’s immune system in response to tumour surface
antigens [3,4]. Although these autoantibodies may sup-
press tumour development, they can cross react with
antigenic proteins on or in neurones leading to nerve
injury and damage. These effects can be more disabling
than those of the tumour itself. The symptoms produced
depend on the particular area of the nervous system
attacked, and range from cerebral and cerebellar syn-
dromes, to ophthalmoplegia, and peripheral nerve injury
[5]. Achalasia has also been reported due to anti-neuronal
antibodies (anti-Hu and to a lesser extent anti-Yo and
N-type Ca
2+ channel anti-neuronal antibodies [6]).
Although there are more than ten detectable anti-neuronal
antibodies found in the sera of patients with neurological
paraneoplastic syndromes, failure to find an antibody
does not mean that one does not exist, only that current
techniques cannot identify it [5].
It is well recognised that renal cell carcinomas may present
in a variety of ways. About five percent of the cases present
as paraneoplastic syndromes including anaemia, amyloi-
dosis, hyperviscosity syndromes and neuropathies. Dys-
phagia in renal cell carcinoma has been reported due to
external oesophageal compression [7] and oesophageal
metastasis [8,9]. This is the first reported case of dysphagia
which is likely to be a consequence of paraneoplastic
autonomic neuropathy secondary to a renal cell carci-
noma. Furthermore, it resulted in the diagnosis and
treatment of an asymptomatic neoplasm. Although the
anti-neuronal and anti-Hu antibody has been detected in
patients with renal cell cancer and coexisting small cell
lung cancer [10], it was not found in this patient. However,
the complete resolution of dysphagia symptoms and
return to normal physiology following resection of the
tumour leads us to believe that the lack of identifiable
antibodies is related to their lab detection limitations
rather than the absence.
Limitation
In our patient’s case, the mild proteinuria detected on
urine dipstick at initial presentation was overlooked.
Looking back through literature it seems there may be an
association between ‘significant (nephrotic range) protei-
nuria’ and renal cell cancer. Proteinuria may be a
diagnostic sign of renal vein involvement with a tumour
Figure 2. Chest radiograph showing a ‘coin shaped lesion’ in
the lower lobe of left lung.
Figure 3. (A) Computed tomography of abdomen and
thorax. showing left sided renal cell carcinoma, (B) Computed
tomography of abdomen and thorax Left sub-pleural lesion
suspicious of metastasis.
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operative significant proteinuria may be a risk factor in
predicting post-nephrectomy decline in renal function
after many years [12,13]. The proposed causes of
proteinuria may vary from venous congestion and
glomerular architectural destruction to paraneoplastic
effects from other tumours (eg. oesophageal, colonic,
transitional cell carcinoma etc) causing glomerulonephro-
pathies. In our patient’s case, the part of the resected
kidney that was not apparently involved by the cancer was
macroscopically normal in appearance although histolo-
gically it showed changes of focal chronic inflammation
with fibrosis, as a result of obstruction. This could explain
his mild proteinuria. Therefore it would seem reasonable
not to ignore simple or isolated proteinuria in clinical
practice.
Conclusion
Although the anti-neuronal antibodies (anti-Hu, anti-Yo
and anti-Ri) were not detectable, we believe that this
patient’s dysphagia was a paraneoplastic manifestation of
the renal cell tumour, an association that has never been
previously reported. We suggest that alternative causes for
dysphagia must be sought if initial investigations are
unhelpful. Importantly, this must include the considera-
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